Microparticle compositions and methods use thereof
US-2024139310-A1 · May 2, 2024 · US
Risperidone microparticles formed by sublimation
US9107832B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9107832-B2 |
| Application number | US-201414156714-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 16, 2014 |
| Priority date | Mar 26, 2002 |
| Publication date | Aug 18, 2015 |
| Grant date | Aug 18, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Provided are microparticles of active pharmaceutical ingredients, drug delivery vehicles comprising same, and methods for making them.
First claim
Opening claim text (preview).
What is claimed is: 1. A pharmaceutical composition comprising microparticles of risperidone obtained by sublimation of a sublimable carrier from a solid solution of risperidone in the sublimable carrier, wherein the microparticles have mean dimensions of about 100 nm to about 10 μm. 2. The pharmaceutical composition of claim 1 wherein the sublimable carrier is menthol, thymol, camphor, t-butanol, trichloro-t-butanol, imidazole, coumarin, acetic acid (glacial)…
Assignees
Inventors
Classifications
- A61K9/167Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Operations & Transport · mapped topic
Operations & Transport · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9107832B2 cover?
- Provided are microparticles of active pharmaceutical ingredients, drug delivery vehicles comprising same, and methods for making them.
- Who is the assignee on this patent?
- Teva Pharma, Teva Pharma
- What technology area does this patent fall under?
- Primary CPC classification A61K9/167. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).